Januvia Revenue Starting to Slip

Type 2 diabetes drug Januvia has generated $50 billion in revenue for Merck since the FDA approved the drug in 2006. Combined sales of Januvia and Janumet, a similar diabetes drug, total more than $75 billion, but revenue is on the decline.
Figures are in millions of dollars.